Diagnosis and Treatment of Polymyalgia Rheumatica.

Area of Science:

• Rheumatology
• Immunology
• Geriatrics

Background:

• Polymyalgia rheumatica (PMR) is a common inflammatory disorder primarily affecting individuals over 50.
• The exact etiology of PMR remains unknown, with potential contributing factors including autoimmune, autoinflammatory, environmental, and genetic elements.
• PMR significantly impacts quality of life due to proximal joint pain and stiffness, leading to reduced mobility.

Purpose of the Study:

• To provide a comprehensive overview of polymyalgia rheumatica.
• To detail the epidemiology, clinical manifestations, diagnostic approaches, and treatment strategies for PMR.
• To highlight the role of medical imaging in PMR diagnosis and management.

Main Methods:

• Review of current literature on polymyalgia rheumatica.
• Analysis of diagnostic criteria and challenges.
• Evaluation of treatment outcomes, particularly with glucocorticoids.

Main Results:

• PMR diagnosis relies on clinical symptoms and blood tests, though these can be inconclusive.
• Symptoms of PMR often overlap with other rheumatic conditions, complicating diagnosis.
• Medical imaging plays a crucial role in confirming diagnosis, monitoring treatment response, and detecting relapses.

Conclusions:

• Early and accurate diagnosis of PMR is essential for effective management.
• Long-term, low-dose oral glucocorticoids are the mainstay of PMR treatment for many patients.
• Further research into the causes of PMR may lead to novel therapeutic approaches.